Welcome to our dedicated page for Aesthetic Medical International Holdings Group news (Ticker: AIH), a resource for investors and traders seeking the latest updates and insights on Aesthetic Medical International Holdings Group stock.
Aesthetic Medical International Holdings Group Ltd. provides aesthetic medical services in China through treatment centers in major mainland cities, with concentration in the Guangdong-Hong Kong-Macau Greater Bay Area and the Yangtze River Delta. Known as Peng’ai, the company offers surgical aesthetic treatments, non-surgical aesthetic treatments, general medical services and other aesthetic services.
Company news commonly covers ADS trading status, including Nasdaq listing compliance and OTCQX quotation, foreign-issuer annual and interim financial reports, and governance changes such as auditor appointments and board or audit committee updates. Operating updates also discuss treatment volumes, customer spending, expense management, digitization initiatives and service-quality programs within its aesthetic medical network.
Aesthetic Medical International Holdings Group (OTCQX: PAIYY), a leading provider of aesthetic medical services in China, has commenced trading its American Depositary Shares (ADSs) on the OTCQX Best Market. Transitioning from the OTC Pink market to the OTCQX platform, the Company aims to leverage the premier market's high financial standards, best practice corporate governance, and compliance with U.S. securities laws to enhance transparency and investor confidence. Chairman ZHANG Chen highlighted that this move is expected to expand AIH's investor base and streamline the investment process, aligning with their goal to deliver continued growth and value to shareholders.
Aesthetic Medical International Holdings Group (Nasdaq: AIH) announced that it has received a delisting notice from the Nasdaq Hearings Panel dated May 17, 2024. The company's securities will be suspended from trading on May 21, 2024, and delisted after Nasdaq files a Form 25 with the SEC. AIH does not plan to appeal this decision. Post-delisting, AIH's American Depositary Shares are expected to be quoted on the OTC market, but there are no guarantees that brokers will continue to trade the ADSs. The company asserts that the delisting will not impact its operations in China's aesthetic medical industry and aims to enhance operational efficiency and performance growth.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.